136 related articles for article (PubMed ID: 32715376)
1. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia.
Abe T; Izumo T; Ueda A; Hayashi M; Ishibashi Y
CEN Case Rep; 2021 Feb; 10(1):42-45. PubMed ID: 32715376
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.
Koshi E; Saito S; Okazaki M; Toyama Y; Ishimoto T; Kosugi T; Hiraiwa H; Jingushi N; Yamamoto T; Ozaki M; Goto Y; Numaguchi A; Miyagawa Y; Kato I; Tetsuka N; Yagi T; Maruyama S
CEN Case Rep; 2021 Feb; 10(1):126-131. PubMed ID: 32940880
[TBL] [Abstract][Full Text] [Related]
3. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
Herth FJF; Sakoulas G; Haddad F
Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
[TBL] [Abstract][Full Text] [Related]
4. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
Ferrey AJ; Choi G; Hanna RM; Chang Y; Tantisattamo E; Ivaturi K; Park E; Nguyen L; Wang B; Tonthat S; Rhee CM; Reddy U; Lau WL; Huang SS; Gohil S; Amin AN; Hsieh L; Cheng TT; Lee RA; Kalantar-Zadeh K
Am J Nephrol; 2020; 51(5):337-342. PubMed ID: 32222713
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Outcomes of Acute Kidney Injury in Patients Infected with COVID-19 in Xiangyang, China.
Yuan H; Liu J; Gao Z; Hu F
Blood Purif; 2021; 50(4-5):513-519. PubMed ID: 33316799
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug.
Karatas M; Tatar E; Simsek C; Yıldırım AM; Ari A; Zengel B; Uslu A
J Med Virol; 2021 Oct; 93(10):5789-5797. PubMed ID: 34050953
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: A case report.
Nourié N; Chamaa MA; Mouawad S; Kotait MM; Finianos S; Azar H; Chelala D
CEN Case Rep; 2021 Aug; 10(3):364-369. PubMed ID: 33502716
[TBL] [Abstract][Full Text] [Related]
8. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
9. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
10. Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome.
Ali S; Khalid S; Afridi M; Akhtar S; Khader YS; Akhtar H
JMIR Public Health Surveill; 2021 May; 7(5):e27609. PubMed ID: 34009133
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure.
Rosa-Guerrero P; Trujillo-Aguilera A; Molina J; Navas A; López-Martín C; Jurado A; Rodríguez-Benot A; Torres-De-Rueda Á
Front Immunol; 2021; 12():671013. PubMed ID: 34046038
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.
Huang L; Wang Y; Wang L; Lv Y; Liu Q
Medicine (Baltimore); 2020 Jul; 99(27):e20956. PubMed ID: 32629703
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
Patel RH; Pella PM; Haider N; Blanco R
Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751
[TBL] [Abstract][Full Text] [Related]
15. Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
Gupta S; Kaushik A; Gupta J
Monaldi Arch Chest Dis; 2020 Oct; 90(4):. PubMed ID: 33059413
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease.
Danieli MG; Piga MA; Paladini A; Longhi E; Mezzanotte C; Moroncini G; Shoenfeld Y
Scand J Immunol; 2021 Nov; 94(5):e13101. PubMed ID: 34940980
[TBL] [Abstract][Full Text] [Related]
17. Immune reactivity during COVID-19: Implications for treatment.
Napoli C; Benincasa G; Criscuolo C; Faenza M; Liberato C; Rusciano M
Immunol Lett; 2021 Mar; 231():28-34. PubMed ID: 33421440
[TBL] [Abstract][Full Text] [Related]
18. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
Rampino T; Gregorini M; Perotti L; Ferrari F; Pattonieri EF; Grignano MA; Valente M; Garrone A; Islam T; Libetta C; Sepe V; Albertini R; Bruno R; Belliato M
Blood Purif; 2021; 50(4-5):566-571. PubMed ID: 33181508
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options for the management of severe COVID-19: A rheumatology perspective.
Mendoza-Pinto C; García-Carrasco M; Munguía Realpozo P; Méndez-Martínez S
Reumatol Clin (Engl Ed); 2021 Oct; 17(8):431-436. PubMed ID: 34625144
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
